https://www.prnewswire.com/news-releases/rosen-national-trial-counsel-encourages-illumina-inc-investors-to-secure-counsel-before-important-january-9-deadline-in-securities-class-action--ilmn-302022390.html
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. (NASDAQ: ILMN) between May 1, 2023...
national trial counselillumina incrosenencouragesinvestors
https://www.illumina.com/company/news-center/press-releases/2017/2295451.html
Illumina and Telegraph Hill Partners Launch Verogen, Inc. to Drive Adoption of Next-Generation Sequencing in the Global Forensic Genomics Market
telegraph hillilluminapartnerslaunchverogen
https://www.ig.com/sg/shares/markets-shares/illumina-inc-ILMN-US
Illumina, Inc. is engaged in providing sequencing-and array-based solutions for genetic and genomic analysis. Its products and services serve... [SG]
illumina incshare pricetradeshareslive
https://finviz.com/news/280674/illumina-inc-ilmn-shares-see-target-boost-as-analysts-see-potential-2026-upside
Stock screener for investors and traders, financial visualizations.
illumina incilmnsharesseetarget
https://capital.com/en-gb/markets/shares/illumina-share-price
Get Illumina Inc (ILMN) real-time share value, investment, rating and financial market information from Capital. Friendly Platforms & Trading today.
illumina incstock priceilmnquotetoday
https://www.fool.com/investing/2017/03/08/1-huge-reason-to-buy-illumina-inc-stock-now.aspx
Illumina stands poised to move past the woes of last year with its new sequencing technology.
illumina inchugereasonbuystock
https://finviz.com/quote.ashx?t=ILMN&ty=c&ta=1&p=d
ILMN - Illumina Inc - Stock screener for investors and traders, financial visualizations.
illumina incstock priceilmnquote
https://www.fool.com/investing/2016/05/26/is-cancer-the-biggest-opportunity-ahead-for-illumi.aspx
Billions of dollars in revenue could be on the horizon if the company can execute on its plans to expand gene sequencing in cancer diagnosis and treatment.
illumina inccancerbiggestopportunityahead